Can-Fite BioPharma CANF
NYSE CANF
$1.89 0.00 (-0.02%)
As of: Oct 21, 2026 · 3:21 PM EDT

Can-Fite BioPharma (CANF) Other Working Capital Changes (2012 - 2013)

Updated

Can-Fite BioPharma's Other Working Capital Changes came in at -$405,000 for FY2025, compared with -$349,000 in FY2024.

Analysis

Can-Fite BioPharma (CANF) Other Working Capital Changes (2012 - 2013) Analysis & Trends

Going back to FY2015, Can-Fite BioPharma's Other Working Capital Changes data covers 11 years.

  • The five-year range for annual Other Working Capital Changes is -$810,000 (FY2022) to $1.4 million (FY2021).
  • Per Business Quant, earlier years put Other Working Capital Changes at -$349,000 in FY2024, -$743,000 in FY2023, -$810,000 in FY2022 and $1.4 million in FY2021.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Eli Lilly 1,136.97 Bn 1,105.55 Bn 19.71 Bn
2 Johnson & Johnson 619.72 Bn 538.25 Bn 17.26 Bn
3 AbbVie 503.40 Bn 476.52 Bn 12.70 Bn
4 Merck 370.15 Bn 324.53 Bn 12.21 Bn
5 Novartis Ag 298.64 Bn 262.63 Bn 11.24 Bn
6 Astrazeneca 261.07 Bn 234.76 Bn 12.86 Bn
7 Amgen 237.00 Bn 192.40 Bn 7.24 Bn
8 Gilead Sciences 191.24 Bn 165.43 Bn 6.22 Bn
9 Pfizer 170.31 Bn 116.96 Bn 10.94 Bn
10 Can-Fite BioPharma 1.56 Mn -18.15 Mn -
Historic Data

Historic Data

Download Data
DateValue
Sep 30, 2013 279.55
Jun 30, 2013 -828.06
Dec 31, 2012 -5,988.91
Sep 30, 2012 2,012.27
Jun 30, 2012 -27,288.04
API Access

Can-Fite BioPharma Other Working Capital Changes API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=other-working-capital-changes&ticker=CANF&period=max&api_key=YOUR_API_KEY